BR9911564A - Composto, processo para produzir um composto, composição farmacêutica, processo para antagonizar o hormÈnio de liberação de gonadotropina em um mamìfero, e, uso de um composto - Google Patents
Composto, processo para produzir um composto, composição farmacêutica, processo para antagonizar o hormÈnio de liberação de gonadotropina em um mamìfero, e, uso de um compostoInfo
- Publication number
- BR9911564A BR9911564A BR9911564-6A BR9911564A BR9911564A BR 9911564 A BR9911564 A BR 9911564A BR 9911564 A BR9911564 A BR 9911564A BR 9911564 A BR9911564 A BR 9911564A
- Authority
- BR
- Brazil
- Prior art keywords
- compound
- releasing hormone
- antagonize
- pharmaceutical composition
- produce
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
"COMPOSTO, PROCESSO PARA PRODUZIR UM COMPOSTO, COMPOSIçãO FARMACêUTICA, PROCESSO PARA ANTAGONIZAR O HORMÈNIO DE LIBERAçãO DE GONADOTROPINA EM UM MAMìFERO, E, USO DE UM COMPOSTO" O composto da presente invenção possui excelente atividade de antagonização do hormónio de liberação de gonadotropina, e é útil para evitar doenças dependentes de hormónio sexual, por exemplo, canceres dependentes de hormónio sexual (por exemplo, câncer prostático, câncer uterino, câncer de mama, tumor pituitário) hipertrofia prostática, histeromioma, endometriose, puberdade precoce, síndrome de amenorréia, síndrome ovariana multiocular, pústulas, etc., ou como um regulador de gravidez (por exemplo, contraceptivo), remédio para a infertilidade ou regulador de menstruação.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP18126398 | 1998-06-26 | ||
JP33300498 | 1998-11-24 | ||
PCT/JP1999/003379 WO2000000493A1 (en) | 1998-06-26 | 1999-06-24 | Thienopyridine compounds, their production and use |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9911564A true BR9911564A (pt) | 2001-10-09 |
Family
ID=27308836
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9911564-6A BR9911564A (pt) | 1998-06-26 | 1999-06-24 | Composto, processo para produzir um composto, composição farmacêutica, processo para antagonizar o hormÈnio de liberação de gonadotropina em um mamìfero, e, uso de um composto |
Country Status (9)
Country | Link |
---|---|
US (1) | US6262267B1 (pt) |
EP (1) | EP1090010A1 (pt) |
AU (1) | AU4393199A (pt) |
BR (1) | BR9911564A (pt) |
CA (1) | CA2331399A1 (pt) |
HU (1) | HUP0102805A3 (pt) |
NO (1) | NO20006479L (pt) |
SK (1) | SK19752000A3 (pt) |
WO (1) | WO2000000493A1 (pt) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4066552B2 (ja) * | 1999-03-16 | 2008-03-26 | コニカミノルタビジネステクノロジーズ株式会社 | 画像形成装置 |
CA2407472A1 (en) * | 2000-06-14 | 2002-10-23 | Takeda Chemical Industries, Ltd. | Sustained release compositions |
CA2423329A1 (en) * | 2000-09-22 | 2003-03-20 | Takeda Chemical Industries, Ltd. | Solid preparations |
US7569570B2 (en) | 2002-01-30 | 2009-08-04 | Takeda Pharmaceutical Company Limited | Thienopyrimidines, process for preparing the same and use thereof |
CA2481391A1 (en) * | 2002-04-12 | 2003-10-23 | Takeda Pharmaceutical Company Limited | Preventives/remedies for hotflash |
GB0307777D0 (en) | 2003-04-04 | 2003-05-07 | Medical Res Council | Conjugate compounds |
MXPA06002296A (es) | 2003-08-29 | 2006-05-22 | Pfizer | Tienopiridina-fenilacetamidas y sus derivados utiles como nuevos agentes antiangiogenicos. |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW449600B (en) | 1994-04-19 | 2001-08-11 | Takeda Chemical Industries Ltd | Condensed-ring thiophene derivatives, their production and use |
CA2192283A1 (en) * | 1995-12-08 | 1997-06-09 | Nobuhiro Suzuki | Prolactin production inhibitory agent |
US6001850A (en) | 1996-04-26 | 1999-12-14 | Takeda Chemical Industries, Ltd. | Thienopyridine derivatives, their production and use |
-
1999
- 1999-06-24 CA CA002331399A patent/CA2331399A1/en not_active Abandoned
- 1999-06-24 WO PCT/JP1999/003379 patent/WO2000000493A1/en not_active Application Discontinuation
- 1999-06-24 US US09/402,206 patent/US6262267B1/en not_active Expired - Fee Related
- 1999-06-24 SK SK1975-2000A patent/SK19752000A3/sk unknown
- 1999-06-24 BR BR9911564-6A patent/BR9911564A/pt not_active Application Discontinuation
- 1999-06-24 AU AU43931/99A patent/AU4393199A/en not_active Abandoned
- 1999-06-24 EP EP99926797A patent/EP1090010A1/en not_active Withdrawn
- 1999-06-24 HU HU0102805A patent/HUP0102805A3/hu unknown
-
2000
- 2000-12-19 NO NO20006479A patent/NO20006479L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU4393199A (en) | 2000-01-17 |
US6262267B1 (en) | 2001-07-17 |
WO2000000493A1 (en) | 2000-01-06 |
CA2331399A1 (en) | 2000-01-06 |
NO20006479D0 (no) | 2000-12-19 |
HUP0102805A2 (hu) | 2001-11-28 |
SK19752000A3 (sk) | 2001-08-06 |
EP1090010A1 (en) | 2001-04-11 |
NO20006479L (no) | 2000-12-19 |
HUP0102805A3 (en) | 2002-04-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Ben-Josef et al. | Hormone-refractory prostate cancer cells express functional follicle-stimulating hormone receptor (FSHR) | |
ATE215081T1 (de) | Gonadotropin releasing hormon- antagonisten | |
BR112014017483A8 (pt) | derivados de espiroindolina e composições farmacêuticas dos mesmos | |
MXPA03001320A (es) | Agentes no peptidicos de la gnrh, composiciones farmaceuticas y procedimientos para su uso. | |
LV11527A (lv) | Jauns progesterona pielietosanas panemiens | |
Jensen et al. | Identification of LH/hCG receptors in rabbit uterus | |
BR9911564A (pt) | Composto, processo para produzir um composto, composição farmacêutica, processo para antagonizar o hormÈnio de liberação de gonadotropina em um mamìfero, e, uso de um composto | |
AR036337A1 (es) | Composicion farmaceutica inyectable que comprende un peptido antagonista de gnrh, un conjunto farmaceutico, metodo de tratamiento y uso de un peptido antagonista de gnrh. | |
AU2003255820A8 (en) | Derivatives of 3-hydroxy-4-(cyclyl-alkylaminoalkyl)-5-phenyl-1h-pyrazole as antagonists of the gonadotropin releasing hormone (gnrh) for use in the treatment of sex hormone related conditions, such as prostatic of uterine cancer | |
Balasch et al. | Pituitary-ovarian suppression by the standard and half-doses of D-Trp-6-luteinizing hormone-releasing hormone depot | |
NO20005145D0 (no) | FremgangsmÕte for behandling av fertilitetsproblemer | |
TW430665B (en) | Thienopyridine compounds for antagonizing gonadotropin-releasing hormone and their production | |
WO2002056903A3 (en) | Methods for treating hormone associated conditions using a combination of lhrh antagonists and specific estrogen receptor modulators | |
Stone et al. | The uptake of some tritiated estrogenic and non-estrogenic steroids by the mouse uterus and vagina in vivo and in vitro | |
DE602004030546D1 (de) | LH zur Verwendung der Erhaltung einer oder mehreren Schwangerschaften durch Induktion der Bildung des sekundären Gelbkörpers. | |
Lövgren et al. | Binding characteristics of estrone, estradiol and estriol to the human myometrial estrogen receptor | |
Vargas Jr | Attempt to induce formation of fibroids with estrogen, in the castrated female rhesus monkey | |
Lo et al. | Gonadoblastoma in patient with Turner's syndrome | |
MA38463A1 (fr) | Dérivés de spiroindoline pour une utilisation en tant qu'antagonistes du récepteur de l'hormone de libération des gonadotrophines | |
DE60122575D1 (de) | 7-HETEROCYCLYL-SUBSTITUIERTE CHINOLIN- UND THIENOi2,3-BöPYRIDIN-DERIVATE ALS ANTAGONISTEN DES GONADOTROPIN-FREISETZENDEN HORMONS | |
Vollmer et al. | Androgen ablation induces tenascin expression in the rat prostate | |
Sasano et al. | Brenner tumor of the ovary: immunoanalysis of steroidogenic enzymes in 23 cases | |
AR036227A1 (es) | USO DE LIGANDOS SELECTIVOS PARA ERa PARA REGULAR LA FERTILIDAD. | |
Ramakrishnan et al. | Progesterone levels in monkeys immunized with Pr-β-hCG-TT after injection of hLH and hCG during luteal phase | |
Chen et al. | Effects of raloxifene at two different doses for ovulation induction on endometrial pinopodes in mice during the implantation window |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA10 | Dismissal: dismissal - article 33 of industrial property law | ||
B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |